GASTROINTESTINAL STROMAL TUMOUR CANCER

Early day motion 125, tabled 15 June 2015 by James Gray (Conservative). Signed by 28 members.

That this House supports the aims of GIST Support UK, the key charity specifically focused on combating gastrointestinal stromal tumour (GIST); acknowledges that GIST is a rare and awful form of cancer commonly found in the digestive system; and calls on the Government to ensure that the only effective third-line drug that treats GIST, the Stivarga form of the drug Regorafenib, remains accessible to patients in England as it is in Scotland to ensure English patients are not second-class citizens.

Signatures by party: Labour 11, Scottish National Party 5, DUP 4, Conservative 3, Social Democratic and Labour Party 3, Independent 1, Labour/Co-operative 1.